Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine
DOI 10.1038/nm850

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats
    Ngoc Lu‐Nguyen, Martin Broadstock, Rafael J. Yáñez‐Muñoz · 2015 · Human Gene Therapy
  2. Acupuncture Treatment for Parkinson’s Disease
    Tetsuya Asakawa, Ying Xia · 2012 · Springer eBooks
  3. Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson’s Disease
    Stephen Polgar, Sheeza Mohamed · 2019 · Journal of Parkinson s Disease
  4. Controlled Catheter Movement Affects Dye Dispersal Volume in Agarose Gel Brain Phantoms
    Jason N. Mehta, Gabrielle McRoberts, Christopher G. Rylander · 2020 · Pharmaceutics
  5. p70S6K on astrocytes protects dopamine neurons from 1‐methyl‐4‐phenylpyridinium neurotoxicity
    Kyoung In Kim, Jeong Yeob Baek, Young Cheul Chung, Jin Han Nam, Won‐Ho Shin, Byung Kwan Jin · 2021 · Glia
  6. Subthalamic Nucleus Stimulation for Parkinson's Disease
    Alim‐Louis Benabid, John Mitrofanis, Stéphan Chabardès, Éric Seigneuret, Napoleon Torres-Martinez, Brigitte Piallat, Abdelhamid Benazzouz, Valérie Fraix, Paul Krack, Pierre Pollak et al. · 2009 · Springer eBooks
  7. Viral vector strategy for glial cell line-derived neurotrophic factor therapy for stroke
    Yun Wang · 2006 · Frontiers in bioscience
  8. Novel Gene Therapeutic Strategies for Neurodegenerative Diseases
    Kathleen A. Maguire‐Zeiss, Howard J. Federoff · 2006 · Springer eBooks
  9. Second chance
    Erika Check · 2007 · Nature Medicine
  10. Promising therapeutic agents for the treatment of Parkinson’s disease
    Majláth, Zsófia, Török, Nóra, Toldi, József, Vécsei, László · 2016 · Expert Opinion on Biological Therapy
  11. Parkinson's Disease Treatment: A Bibliometric Analysis
    Billy McBenedict, Wilhelmina N Hauwanga, Gustavo P Ienaco, Dulci Petrus, Syeda Sukaina Kazmi, Jonatha Machado Lima, Barakat B Onabanjo, Felix Asaju, Sujood Musa Awadelseed, Shivadeva Selvamani et al. · 2024 · Cureus
  12. Adaptive immunity in the pathogenesis and treatments of Parkinson’s disease
    Xiaoqing Du, Samia Akter, Davina B. Oludipe, Susmita Sil, Chen Zhang, Howard Eliot Gendelman, Rodney Lee Mosley · 2025 · NeuroImmune Pharmacology and Therapeutics
  13. Regenerative Therapy in Experimental Parkinsonism: Mixed Population of Differentiated Mouse Embryonic Stem Cells, Rather Than Magnetically Sorted and Enriched Dopaminergic Cells Provide Neuroprotection
    Debasmita Tripathy, Poonam Verma, Dominic Ngima Nthenge-Ngumbau, Meghna Banerjee, Kochupurackal P. Mohanakumar · 2014 · CNS Neuroscience & Therapeutics
  14. Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies
    Zinovia Maria Kefalopoulou, Icíar Avilés-Olmos, Thomas Foltynie · 2011 · Parkinson s Disease
  15. Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism
    David James Brooks · 2021 · Neurotherapeutics
  16. Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases
    Youngpyo Nam, Gyeong Joon Moon, Sang Ryong Kim · 2021 · International Journal of Molecular Sciences
  17. Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells
    Dzhirgala Shamadykova, Dmitry Y. Panteleev, N. N. Kust, Ekaterina Savchenko, Ekaterina Yu. Rybalkina, Alexander V. Revishchin, Galina Valerievna Pavlova · 2021 · PLoS ONE
  18. Practically Defined Off‐State Dyskinesia Following Repeated I ntra p utamenal Glial Cell Line–Derived Neurotrophic Factor Administration
    Katherine Lloyd, Michael Lawton, Alan L. Whone · 2022 · Movement Disorders
  19. [Surgical treatment for Parkinson's disease].
    Jorge Guridi, María Rodríguez‐Oroz, Manuel Jesús Manrique · 2004 · PubMed
  20. Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery—A retrospective analysis of patients that underwent surgery between 1993 and 2001
    Radu Constantinescu, Kaj Blennow, Lars Rosengren, Barbro Eriksson, Thordis Gudmundsdottir, Yvonne Jansson, Bo Johnels, Annika Renck, Filip Bergquist · 2018 · Clinical Neurology and Neurosurgery
  21. Neurotrophic Factors and Parkinson’s Disease: The Emergence of a New Player?
    William T. Dauer · 2007 · Science s STKE
  22. Tratamiento quirúrgico de la enfermedad de Parkinson
    Jorge Guridi, María Rodríguez‐Oroz, Mariuxi Alexandra Ávila Manrique · 2004 · Neurocirugía
  23. Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al.
    Barry J. Hoffer · 2011 · Experimental Neurology
  24. EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) ON STEM/PROGENITOR CELL PROLIFERATION AND DIFFERENTIATION
    Yan Chen · 2005 · UKnowledge (University of Kentucky)
  25. Towards an implantale intelligent CMOS neurotrophic factor delivery micro neural prosthetic for Parkinson's disease
    Mohammad Poustinchi, Sam Musallam · 2013 · International IEEE/EMBS Conference on Neural Engineering
  26. Minimally invasive nasal infusion (MINI) approach for CNS delivery of protein therapeutics: A case study with ovalbumin
    Valentina Di Francesco, Andy Jian Kai Chua, Elham Davoudi, Jonghan Kim, Benjamin Saul Bleier, Mansoor M. Amiji · 2024 · Journal of Controlled Release
  27. Disease modifying therapies for Parkinson's disease: Novel targets
    Nirosen Vijiaratnam, Thomas Foltynie · 2021 · Neuropharmacology
  28. The dual role of striatal interneurons: circuit modulation and trophic support for the basal ganglia
    Elliot Wegman, Marlena Wosiski‐Kuhn, Yu Luo · 2023 · Neural Regeneration Research
  29. Neurotrophic Factors in Parkinson’s Disease: Clinical Trials
    Arun Kumar Mahato, Märt Saarma · 2024 · Stem cell biology and regenerative medicine
  30. Neurotrophin gene therapy for Alzheimer‘s disease
    Armin Blesch · 2006 · Future Neurology
  31. A preliminary evaluation of glial cell line‐derived neurotrophic factor (GDNF) levels in cerebrospinal fluid across various gestational ages and clinical conditions of the neonate
    Rahul Rajkumar, Bhavana Bhaya, Divya Mamilla, Theresa Czech, Esther Kisseih, Arun Saini, Nitin Shashikant Chouthai · 2017 · International Journal of Developmental Neuroscience
  32. Preganglionic Parasympathetic Denervation Rabbit Model for Innervation Studies
    Hiroshi Toshida, Chikako Suto · 2018 · Cornea
  33. Robotic Applications in Neurosurgery
    M. Sam · 2008
  34. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum
    Wayne A. Cass, Laura E. Peters · 2010 · Neurochemistry International
  35. Neurological disorders and neural regeneration, with special reference to Parkinson’s disease and cerebral ischemia
    Isao Date, Takao Yasuhara · 2009 · Journal of Artificial Organs
  36. Molecular genetics of Parkinson’s disease
    Maria I. Shadrina, Petr A. Slominsky · 2006 · Russian Journal of Genetics
  37. Imaging of genetic and degenerative disorders primarily causing Parkinsonism
    David James Brooks · 2016 · Handbook of clinical neurology
  38. Animal Models of Parkinson's Disease to Aid Drug Discovery and Development
    Kalpana Merchant, Marie-Françoise Chesselet, Shu‐Ching Hu, Stanley Fahn · 2008 · Elsevier eBooks
  39. GDNF receptor agonist supports dopamine neurons in vitro and protects their function in animal model of Parkinson’s
    Arun Kumar Mahato, Juho‐Matti Renko, Jaakko J. Kopra, Tanel Visnapuu, Ilari Korhonen, Nita Pulkkinen, Maxim M. Bespalov, Eric Ronken, Petteri T. Piepponen, Merja H. Voutilainen et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Biology of RET receptor and its ligands: focus on the nervous system
    Arun Kumar Mahato, Märt Saarma · 2025 · Endocrine Related Cancer
  41. Injection of HGF Plasmid cDNA to Prevent Manifestation of Parkinson Disease: A Preclinical Study using a Primate Model
    Hiromi Koike, Akihiko Ishida, Takuya Hayashi, Munehisa Shimamura, Shinya Mizuno, Toshikazu Nakamura, Hidehiro Iida, Toshio Ogihara, Yasufumi Kaneda, Ryuichi Morishita · 2009 · The Open Gene Therapy Journal
  42. Therapeutic Strategies in Neurodegenerative Diseases
    Kristi M. Anderson, Rodney Lee Mosley · 2016 · Springer eBooks
  43. Incomplete copolymer degradation of in situ chemotherapy
    Pierre Bourdillon, Tanguy Boissenot, Lauriane Goldwirt, Julien Nicolas, Caroline Apra, Alexandre C. Carpentier · 2018 · Journal of Materials Science Materials in Medicine
  44. Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor
    Zhongwei Liu, Wenqiang Li, Junkui Wang, Xiancang Ma, Chen Liang, Peng Liu, Zheng Chu, Yonghui Dang · 2014 · Journal of Zhejiang University SCIENCE B
  45. Caribbean parkinsonism and other atypical Parkinsonian disorders
    EDUARDO S. TOLOSA, Daniela Calandrella, Marisol Gallardo · 2004 · Parkinsonism & Related Disorders
  46. Identification of glial‐cell‐line‐derived neurotrophic factor‐regulated proteins of striatum in mouse model of Parkinson disease
    Zhen Hong, Jun Liu, Xia Li, Jing Pan, Qin Xiao, Guoqiang Lü, Liang Liang, Shengdi Chen · 2009 · PROTEOMICS - CLINICAL APPLICATIONS
  47. Construction of Targeting Vector for Expressing Human GDNF in Cattle Mammary Gland
    Xueming Zhang, Ying Wu, Fenhua Luo, Huimin Su, Yin Bai, Yue Hou, Boyang Yu · 2009 · Applied Biochemistry and Biotechnology
  48. 3.217 CDNF PROTECTS THE NIGROSTRIATAL DOPAMINE SYSTEM AND PROMOTES RECOVERY AFTER MPTP TREATMENT IN MICE
    Mikko Airavaara, B. K. Harvey, Merja H. Voutilainen, H. Shen, Jenny Chou, Päivi Lindholm, Maria Lindahl, Raimo K. Tuominen, Märt Saarma, Y. Wang et al. · 2011 · Parkinsonism & Related Disorders
  49. Direct and indirect parameter imaging methods for dynamic PET
    Xin Hua Mao, Shujun Zhao, Dongfang Gao, Zhanli Hu, Na Zhang · 2021 · Biomedical Physics & Engineering Express
  50. Intrathecal Injection of Mesenchymal Stromal Cell Cultured on 3D Fiber Ameliorates Multiple Organ Damage in Murine Lupus
    Yuki Saito, Maki Miyajima, Sena Yamamoto, Norihiro Miura, Tsukasa Sato, Arisa Kita, Shogo Ijima, Mineko Fujimiya, Takako Chikenji · 2022 · Stem Cells Translational Medicine
  51. Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications
    Liang‐Fong Wong, Lucy Goodhead, Christine M. A. Prat, Kyriacos A. Mitrophanous, Susan M. Kingsman, Nicholas D. Mazarakis · 2005 · Human Gene Therapy
  52. Focal opening of the neuronal plasma membrane by shock-induced bubble collapse for drug delivery: a coarse-grained molecular dynamics simulation
    Mi Zhou, Tong Wei, Lingzhi Gu, Hong Wei Yang, Ming Li, Yang Zhou · 2022 · Physical Chemistry Chemical Physics
  53. Potential sources of stem cells as a regenerative therapy for Parkinson's disease
    Abir El Sadik · 2010 · Stem Cells and Cloning Advances and Applications
  54. Treatment Options in Patients with Prion Disease - the Role of Long Term Cerebroventricular Infusion of Pentosan Polysulphate
    Nikolai G. Rainov, Ian Roger Whittle, Katsumi Doh‐ura · 2006 · Springer eBooks
  55. Aspectos moleculares y prospectos de terapias en la enfermedad de Parkinson
    Hebert Luís Hernández-Montiel · 2006 · Redalyc (Universidad Autónoma del Estado de México)
  56. Agonizing over dopaminergic replacement therapy—lessons from animal models of parkinson’s disease
    A. Jon Stoessl · 2003 · Experimental Neurology
  57. Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
    Richie E. Kohman, Xue Han, Benjamin Saul Bleier · 2014 · Journal of Visualized Experiments
  58. Effect of neurturin on multipotent cells isolated from the adult skeletal muscle
    Patrick Vourc’h, Benjamin Lacar, Laurence Mignon, Paul A. Lucas, Warren Young, Marie‐Françoise Chesselet · 2005 · Biochemical and Biophysical Research Communications
  59. Cell therapy for Parkinson's disease: have the glory days gone?
    Alberto Albanese · 2011 · The Lancet Neurology
  60. MAXIMUM A POSTERIORI RECONSTRUCTION OF PATLAK PARAMETRIC IMAGE FROM SINOGRAMS IN DYNAMIC PET
    Guobao Wang, Jinyi Qi · 2007 · IEEE International Symposium on Biomedical Imaging (ISBI)
  61. Positron Emission Tomography and Embryonic Dopamine Cell Transplantation in Parkinson’s Disease
    Yilong Ma, VIJAY M. DHAWAN, Curt R. Freed, Stanley Fahn, David Eidelberg · 2007 · Humana Press eBooks
  62. Future therapies for Parkinson's disease
    Robert A. Hauser, Kelly E. Lyons · 2004 · Neurologic Clinics
  63. Cell therapies for neurological disease – from bench to clinic to bench
    Timothy Harrower, Roger A. Barker · 2005 · Expert Opinion on Biological Therapy
  64. Two-year feasibility and safety of open-label autologous peripheral nerve tissue implantation during deep brain stimulation in patients with Parkinson's disease
    Jorge E. Quintero, Monica J. Chau, John T. Slevin, Lisa Koehl, Julie A. Gurwell, Elizabeth R. Wallace, Richard J. Kryscio, Riham H. El Khouli, Amelia Jane Anderson-Mooney, Frederick A. Schmitt et al. · 2025 · Journal of Parkinson s Disease
  65. Gene Therapy for Parkinson’s Disease
    Michael Douglas, Jonathan Hazlehurst · 2011 · InTech eBooks
  66. Stem cells and regenerative therapies for Parkinson’s disease
    Roger A. Barker, Farrell · 2012 · Degenerative Neurological and Neuromuscular Disease
  67. Secretory factors of human neuroblastoma (IMR-32) and human glioblastoma (U87MG) cell lines induce neurite outgrowths in PC12 cells.
    Ravindra M. Satpute, Rajpal Singh Kashyap, Rani P Kainthla, Hemant J. Purohit, Girdhar M. Taori, Hatim F. Daginawala · 2006 · PubMed
  68. Medical Treatment of Parkinson Disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett, Peter G. Jenner · 2007 · Elsevier eBooks
  69. Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson’s Disease
    Rahul Rahul, Yasir Hasan Siddique · 2021 · CNS & Neurological Disorders - Drug Targets
  70. Stem cell therapy for Parkinson's disease
    Lars M. Björklund · 2004 · Dialogues in Clinical Neuroscience
  71. Mechanism of extracellular space changes in cryptococcal brain granuloma revealed by MRI tracer
    Nuerbiyemu Abulikemu, Xin Gao, Wei Wang, Qingyuan He, Gang Wang, Tao Jiang, Xiaodong Wang, Yumeng Cheng, Min Chen, Yanran Li et al. · 2022 · Frontiers in Neuroscience
  72. Subthalamic nucleus deep brain stimulation does not alter growth factor expression in a rat model of stable dopaminergic deficiency
    Meike Statz, Frederike Schleuter, Hanna Weber, Maria Kober, Franz Veit Plocksties, Dirk Timmermann, Alexander Storch, Mareike Fauser · 2023 · Neuroscience Letters
  73. Oxidative stress induced by sustained supraphysiological intrastriatal GDNF delivery is prevented by dose regulation
    Marcelo Duarte Azevedo, Naika Prince, Marie Humbert‐Claude, Virginia Mesa-Infante, Cheryl Jeanneret, Valentine Golzné, Kevin De Matos, Benjamin Boury Jamot, Fulvio Magara, Tomás González‐Hernández et al. · 2023 · Molecular Therapy — Methods & Clinical Development
  74. Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF
    Elena Aleksandrovna Belova, Christopher L. Shaffer, Patrick E. Trapa · 2017 · Medical & Biological Engineering & Computing
  75. Nigrostriatal Neurons in Rat Express the Glial Cell Line‐Derived Neurotrophic Factor Receptor Subunit c‐RET
    Yan‐Qin Wang, Ganlan Bian, Lichun Wei, Rong Yue Cao, Peng Ye, Liang‐Wei Chen · 2007 · The Anatomical Record
  76. Exercise Training and Rehabilitation of the Brain in Parkinson´s Disease
    Muhammed D. Al-Jarrah · 2013 · Clinical Medicine Research
  77. INTRATHECAL DELIVERY OF PROTEIN THERAPEUTICS TO TREAT GENETIC DISEASES INVOLVING THE CNS
    Lawrence R. Charnas, Zahra Shahrokh, Perry Calias · 2010
  78. Parkinson’s Disease II: Replacement of Dopamine and Restoration of Striatal Function
    Christian Winkler, Deniz Kirik · 2004 · Springer eBooks
  79. Subthalamic Deep Brain Stimulation for Parkinson's Disease
    Alim Louis Benabid, John Mitrofanis, Stéphan Chabardès, Éric Seigneuret, Napoleon Torres-Martinez, Brigitte Piallat, Abdelhamid Benazzouz, Valérie Fraix, Paul Krack, Pierre Pollak et al. · 2011 · Elsevier eBooks
  80. Neuroimaging in Parkinson’s disease
    David James Brooks · 2004 · Neurotherapeutics
  81. REMOVED: Stem Cells and Heart Disease
    Piero Anversa, Annarosa Leri, Bernardo Nadal‐Ginard, Jan Kajstura · 2014 · Elsevier eBooks
  82. Imaging studies in drug development: Parkinson's disease
    David James Brooks · 2005 · Drug Discovery Today Technologies
  83. Adult Stem Cells for the Treatment of Neurological Disease
    Claire M Rice, Neil J. Scolding · 2009 · Methods in molecular biology
  84. Drug delivery strategies for paediatric diffuse midline gliomas
    Stefana Duca, Sara Jamshidi Parvar, Luke Kumeta, Tracey Dawn Bradshaw, Weng C. Chan, Felicity de Cogan, Karolina Dziemidowicz, Pavel Gershkovich, Maria Marlow, Christopher J. Morris et al. · 2025 · Advanced Drug Delivery Reviews
  85. Advances in bioelectronics for neural interfacing
    Junpeng Li, Xiao Yang · 2025 · MRS Communications
  86. Parkinson's Disease: Cell Vulnerability and Disease Progression
    Xavier d’Anglemont de Tassigny, Alberto Pascual, José López‐Barneo · 2015 · Frontiers research topics
  87. Insights into receptor tyrosine kinases signaling in neurodegenerative disorders
    Puneet Kaur Randhawa, Amteshwar Singh Jaggi, Anjana Bali · 2023 · Elsevier eBooks
  88. Blood-based therapies to combat neurodegenerative diseases
    Lee Jy, Mervyn Chen Xi Lim, Rhun Yian Koh, Min Tze Tsen, Soi Moi Chye · 2024 · Metabolic Brain Disease
  89. The emerging portrait of GDNF: A small neuroinductive isoform named djGDNF47
    Dzhirgala Shamadykova, Dmitry Y. Panteleev, Ekaterina Savchenko, Victoria Parshina, Andrey V. Golovin, Alexander V. Revishchin, Galina Valerievna Pavlova · 2025 · International Journal of Biological Macromolecules
  90. The myeloid cell-driven transdifferentiation of endothelial cells into pericytes promotes the restoration of BBB function and brain self-repair after stroke
    Tingbo Li, Ling Yang, Jiaqi Tu, Yufan Hao, Zhu Zhu, Yingjie Xiong, Qingzhu Gao, Lili Zhou, Guanglei Xie, Dongdong Zhang et al. · 2025 · eLife
  91. A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function
    O. Meagan Littrell, Joshua L. Fuqua, April R. Hatcher, Jadwiga T. Turchan-Cholewo, Erin R. Hascup, Peter F. Huettl, François Pomerleau, Luke H. Bradley, Don Marshall Gash, Greg A. Gerhardt · 2012 · Neuropeptides
  92. Low power CMOS neurochemical biosensor application in an implantable intelligent neurotrophic factor delivery hybrid microsystem for Parkinson's
    Mohammad Poustinchi, Sam Musallam · 2014 · Middle East Conference on Biomedical Engineering
  93. GDNF and Related Proteins
    Heike Peterziel, Jens Strelau · 2006 · Springer eBooks
  94. Gene Therapy for Parkinson’s Disease: AAV5-Mediated Delivery of Glial Cell Line-Derived Neurotrophic Factor (GDNF)
    Bas Blits, Deniz Kirik, Harald Petry, Stephan Hermening · 2015 · Neuromethods
  95. Transplants of CNTF-producing Cells for the Treatment of Huntington's Disease
    Carole Escartin, Philippe Hantraye, Nicole Déglon · 2007 · Elsevier eBooks
  96. Intestinal flora imbalance affects the prognosis of Parkinson's disease by regulating the expression of fecal microRNA-146a and GDNF: A Preliminary Study
    Hongchun Wei, Yinbao Hu, Liqing Yang · 2021 · Archives of Medical Science
  97. Stem cells and regenerative medicine
    Alexis J. Joannides, Bhuvaneish Thangaraj Selvaraj, Siddharthan Chandran · 2020
  98. GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson's Disease.
    Juho‐Matti Renko, Merja H. Voutilainen, Tanel Visnapuu, Yulia A. Sidorova, Märt Saarma, Raimo K. Tuominen · 2020 · PubMed
  99. SC79 promotes efficient entry of GDNF liposomes into brain parenchyma to repair dopamine neurons through reversible regulation of tight junction proteins
    Xiaomei Wu, Li Wang, Kai Wang, Ke Jia, Sufen Li, Tingting Meng, Hong Yuan, Qirui Zhang, Fuqiang Hu · 2022 · Nano Research
  100. Current Neurosurgical Treatments for Parkinson's Disease: Where Did They Come From?
    Benjamin L. Walter, Aviva Abosch, Jerrold L. Vitek · 2005 · Elsevier eBooks